Shenzhen New Industries Biomedical Engineering Co., Ltd. Stock
Equities
300832
CNE100003T39
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
68.95 CNY | +5.48% | +11.43% | -11.83% |
Capitalization | 54.18B 7.45B 7.1B 6.6B 5.89B 10.48B 631B 11.54B 82.02B 30.44B 259B 27.99B 27.36B 1,111B | P/E ratio 2024 * |
27.3x | P/E ratio 2025 * | 22.1x |
---|---|---|---|---|---|
Enterprise value | 52.6B 7.23B 6.89B 6.41B 5.72B 10.18B 613B 11.2B 79.64B 29.56B 251B 27.18B 26.57B 1,079B | EV / Sales 2024 * |
11.1x | EV / Sales 2025 * | 8.81x |
Free-Float |
38.88% | Yield 2024 * |
1.76% | Yield 2025 * | 2.14% |
1 day | +5.48% | ||
1 week | +11.43% | ||
Current month | +5.48% | ||
1 month | +2.31% | ||
3 months | +3.11% | ||
6 months | -8.94% | ||
Current year | -11.83% |
Director | Title | Age | Since |
---|---|---|---|
Wei Rao
CEO | Chief Executive Officer | 60 | 2012-08-16 |
Chen Liu Ding
DFI | Director of Finance/CFO | 49 | 2012-08-16 |
Jie Ma
HRO | Human Resources Officer | 31 | 2021-04-30 |
Manager | Title | Age | Since |
---|---|---|---|
Wei Rao
CHM | Chairman | 60 | 2012-08-16 |
Dai Na Wang
BRD | Director/Board Member | 61 | 2018-09-09 |
Qing Wei Zhang
BRD | Director/Board Member | 49 | 2012-07-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.68% | 2 M€ | -14.14% | ||
0.67% | 1 M€ | -20.08% | - |
Change | 5d. change | 1-year change | 3-years change | Capi. ($) | ||
---|---|---|---|---|---|---|
+5.48% | +11.43% | -5.04% | +41.87% | 7.09B | ||
-1.37% | -1.22% | -3.32% | -19.82% | 12.31B | ||
+0.35% | -1.52% | +21.40% | +235.25% | 6.21B | ||
0.00% | -2.42% | +21.10% | -42.67% | 5.95B | ||
-0.25% | +0.34% | +34.90% | -62.99% | 4.4B | ||
-0.37% | +3.72% | -13.43% | -14.92% | 3.67B | ||
+0.18% | +1.72% | +23.53% | -59.46% | 2.79B | ||
+0.79% | -0.98% | +17.11% | +109.01% | 2.76B | ||
+3.58% | +7.65% | -64.00% | -88.90% | 1.92B | ||
+8.20% | +6.55% | +27.02% | -36.57% | 1.74B | ||
Average | +1.66% | +2.66% | +5.93% | +6.08% | 4.88B | |
Weighted average by Cap. | +0.93% | +1.82% | +6.60% | +16.94% |
2024 * | 2025 * | |
---|---|---|
Net sales | 4.74B 651M 621M 577M 515M 916M 55.19B 1.01B 7.17B 2.66B 22.62B 2.45B 2.39B 97.15B | 5.83B 802M 764M 711M 634M 1.13B 67.95B 1.24B 8.83B 3.28B 27.84B 3.01B 2.95B 120B |
Net income | 1.98B 272M 259M 241M 215M 383M 23.04B 421M 2.99B 1.11B 9.44B 1.02B 999M 40.57B | 2.45B 337M 321M 298M 266M 474M 28.53B 521M 3.71B 1.38B 11.69B 1.27B 1.24B 50.23B |
Net Debt | -1.57B -216M -206M -192M -171M -305M -18.34B -335M -2.38B -885M -7.52B -813M -795M -32.29B | -2.8B -384M -366M -341M -304M -541M -32.58B -595M -4.23B -1.57B -13.35B -1.44B -1.41B -57.35B |
Date | Price | Change | Volume |
---|---|---|---|
24-12-02 | 68.95 ¥ | +5.48% | 8,102,336 |
24-11-29 | 65.37 ¥ | +2.85% | 4,768,476 |
24-11-28 | 63.56 ¥ | -2.00% | 3,496,161 |
24-11-27 | 64.86 ¥ | +1.84% | 4,494,524 |
24-11-26 | 63.69 ¥ | +3.90% | 6,727,170 |
End-of-day quote Shenzhen S.E., December 01, 2024
More quotesQuarterly revenue - Rate of surprise
- Stock Market
- Equities
- 300832 Stock